High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.1M
$2,051,295
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| BCAX |
Bicara Therapeutics Inc.
|
COO
Other
|
2026-03-03 | $48,858 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2026-03-03 | $315,893x2 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
Other
|
2026-02-25 | $11,779 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2026-02-25 | $65,501x2 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2026-01-22 | $69,296 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2026-01-15 | $2,685 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
Equity Compensation
|
2025-12-15 | $30,318x2 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-12-15 | $233,548x2 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
Other
|
2025-11-21 | $30,318 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-11-21 | $225,588x2 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
Other
|
2025-10-15 | $30,318 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-10-15 | $226,942x2 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
Other
|
2025-10-07 | $30,318 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-10-07 | $196,844x2 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
Other
|
2025-10-06 | $90,955 | M | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-10-06 | $714,998x2 | S | Form 4 |